269 related articles for article (PubMed ID: 20668671)
21. Profiling of microRNA-mRNA reveals roles of microRNAs in cervical cancer.
Ma D; Zhang YY; Guo YL; Li ZJ; Geng L
Chin Med J (Engl); 2012 Dec; 125(23):4270-6. PubMed ID: 23217399
[TBL] [Abstract][Full Text] [Related]
22. A three miRNAs signature predicts survival in cervical cancer using bioinformatics analysis.
Liang B; Li Y; Wang T
Sci Rep; 2017 Jul; 7(1):5624. PubMed ID: 28717180
[TBL] [Abstract][Full Text] [Related]
23. Identification of miRNAs in cervical mucus as a novel diagnostic marker for cervical neoplasia.
Kawai S; Fujii T; Kukimoto I; Yamada H; Yamamoto N; Kuroda M; Otani S; Ichikawa R; Nishio E; Torii Y; Iwata A
Sci Rep; 2018 May; 8(1):7070. PubMed ID: 29728572
[TBL] [Abstract][Full Text] [Related]
24. Use of Mature miRNA Strand Selection in miRNAs Families in Cervical Cancer Development.
Granados-López AJ; Ruiz-Carrillo JL; Servín-González LS; Martínez-Rodríguez JL; Reyes-Estrada CA; Gutiérrez-Hernández R; López JA
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28216603
[TBL] [Abstract][Full Text] [Related]
25. Global microRNA profiles in cervical squamous cell carcinoma depend on Drosha expression levels.
Muralidhar B; Goldstein LD; Ng G; Winder DM; Palmer RD; Gooding EL; Barbosa-Morais NL; Mukherjee G; Thorne NP; Roberts I; Pett MR; Coleman N
J Pathol; 2007 Aug; 212(4):368-77. PubMed ID: 17471471
[TBL] [Abstract][Full Text] [Related]
26. Deregulated microRNAs in triple-negative breast cancer revealed by deep sequencing.
Chang YY; Kuo WH; Hung JH; Lee CY; Lee YH; Chang YC; Lin WC; Shen CY; Huang CS; Hsieh FJ; Lai LC; Tsai MH; Chang KJ; Chuang EY
Mol Cancer; 2015 Feb; 14():36. PubMed ID: 25888956
[TBL] [Abstract][Full Text] [Related]
27. Triage of high-risk HPV-positive women in population-based screening by miRNA expression analysis in cervical scrapes; a feasibility study.
Babion I; Snoek BC; Novianti PW; Jaspers A; van Trommel N; Heideman DAM; Meijer CJLM; Snijders PJF; Steenbergen RDM; Wilting SM
Clin Epigenetics; 2018; 10():76. PubMed ID: 29930741
[TBL] [Abstract][Full Text] [Related]
28. Expression level of miRNA-210-3p in cervical cancer and its prognostic potential.
Shao MX; Qu AZ; Wang YQ; Zhong YY
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6583-6588. PubMed ID: 32633346
[TBL] [Abstract][Full Text] [Related]
29. Characterization of the microRNA profile in early-stage cervical squamous cell carcinoma by next-generation sequencing.
Lin W; Feng M; Chen G; Zhou Z; Li J; Ye Y
Oncol Rep; 2017 Mar; 37(3):1477-1486. PubMed ID: 28098890
[TBL] [Abstract][Full Text] [Related]
30. Quantifying mRNA and microRNA with qPCR in cervical carcinogenesis: a validation of reference genes to ensure accurate data.
Leitão Mda C; Coimbra EC; de Lima Rde C; Guimarães Mde L; Heráclio Sde A; Silva Neto Jda C; de Freitas AC
PLoS One; 2014; 9(11):e111021. PubMed ID: 25365304
[TBL] [Abstract][Full Text] [Related]
31. MiR-22-3p Regulates Cell Proliferation and Inhibits Cell Apoptosis through Targeting the eIF4EBP3 Gene in Human Cervical Squamous Carcinoma Cells.
Lv KT; Liu Z; Feng J; Zhao W; Hao T; Ding WY; Chu JP; Gao LJ
Int J Med Sci; 2018; 15(2):142-152. PubMed ID: 29333098
[No Abstract] [Full Text] [Related]
32. Identification of microRNA expression signature for the diagnosis and prognosis of cervical squamous cell carcinoma.
Bozgeyik E; Tepe NB; Bozdag Z
Pathol Res Pract; 2020 Nov; 216(11):153159. PubMed ID: 32841775
[TBL] [Abstract][Full Text] [Related]
33. Potential role of microRNAs in the treatment and diagnosis of cervical cancer.
Shen S; Zhang S; Liu P; Wang J; Du H
Cancer Genet; 2020 Oct; 248-249():25-30. PubMed ID: 32987255
[TBL] [Abstract][Full Text] [Related]
34. The expression of miR-21 and miR-143 is deregulated by the HPV16 E7 oncoprotein and 17β-estradiol.
Gómez-Gómez Y; Organista-Nava J; Ocadiz-Delgado R; García-Villa E; Leyva-Vazquez MA; Illades-Aguiar B; Lambert PF; García-Carrancá A; Gariglio P
Int J Oncol; 2016 Aug; 49(2):549-58. PubMed ID: 27278606
[TBL] [Abstract][Full Text] [Related]
35. Microarray profile of micro-ribonucleic acid in tumor tissue from cervical squamous cell carcinoma without human papillomavirus.
Zhang Y; Dai Y; Huang Y; Ma L; Yin Y; Tang M; Hu C
J Obstet Gynaecol Res; 2009 Oct; 35(5):842-9. PubMed ID: 20149030
[TBL] [Abstract][Full Text] [Related]
36. Gene expression analysis of preinvasive and invasive cervical squamous cell carcinomas identifies HOXC10 as a key mediator of invasion.
Zhai Y; Kuick R; Nan B; Ota I; Weiss SJ; Trimble CL; Fearon ER; Cho KR
Cancer Res; 2007 Nov; 67(21):10163-72. PubMed ID: 17974957
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA expression profiling of male breast cancer.
Fassan M; Baffa R; Palazzo JP; Lloyd J; Crosariol M; Liu CG; Volinia S; Alder H; Rugge M; Croce CM; Rosenberg A
Breast Cancer Res; 2009; 11(4):R58. PubMed ID: 19664288
[TBL] [Abstract][Full Text] [Related]
38. Aberrant expression of miR-20a and miR-203 in cervical cancer.
Zhao S; Yao DS; Chen JY; Ding N
Asian Pac J Cancer Prev; 2013; 14(4):2289-93. PubMed ID: 23725129
[TBL] [Abstract][Full Text] [Related]
39. A microRNA-Messenger RNA Regulatory Network and Its Prognostic Value in Cervical Cancer.
Liu J; Yang J; Gao F; Li S; Nie S; Meng H; Sun R; Wan Y; Jiang Y; Ma X; Cheng W
DNA Cell Biol; 2020 Jul; 39(7):1328-1346. PubMed ID: 32456463
[TBL] [Abstract][Full Text] [Related]
40. Altered microRNA expression associated with chromosomal changes contributes to cervical carcinogenesis.
Wilting SM; Snijders PJ; Verlaat W; Jaspers A; van de Wiel MA; van Wieringen WN; Meijer GA; Kenter GG; Yi Y; le Sage C; Agami R; Meijer CJ; Steenbergen RD
Oncogene; 2013 Jan; 32(1):106-16. PubMed ID: 22330141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
